With the emergence of new mechanisms and new treatment methods, there are higher requirements for protecting the safety of subjects in clinical studies. At the same time, clinical research is becoming more complex, the promotion of ICH E17, and global multicenter research has gradually become the mainstream, which has brought more challenges to clinical research quality management. JMP China's pharmaceutical industry data analysis consultant will demonstrate how to customize interactive medical monitoring reports based on standard/non-standard clinical data, which will help review the status of subjects from multiple angles and provide quality assurance for ongoing monitoring of trials.
